miscsubjectsAI governance
Evidence review

Retatrutide for Neuropathy: Evidence Review

bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `retatrutide-neuropathy`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/retatrutide-neuropathy

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/retatrutide-neuropathy/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/retatrutide-neuropathy/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/retatrutide-neuropathy/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/retatrutide-neuropathy/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

Why Retatrutide might help you

  1. What keeps failing: Excess body weight multiplies compressive load on spine, hips, knees, and plantar fascia.
  2. What Retatrutide is studied to do: Studied for GLP-1/GIP/glucagon-driven weight loss — less mechanical load, not direct disc regeneration.
  3. Therefore for you: If that layer is part of your problem, Retatrutide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • Retatrutide → metabolic load / body weight

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 1
  • Claims tagged human evidence: 3
  • Claims tagged preclinical (animal/lab): 0
  • Claims tagged anecdotal: 2
  • Reddit posts catalogued: 4
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 12

Quantified confidence (this ledger): 0.42 / 1.00 — low–moderate — mostly preclinical

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Retatrutide—A Game Changer (source s9)

Phase 2 trial weight and HbA1c results.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

What people say on Reddit

Neuropathy? — Reddit, r/Retatrutide (source s0)

User report of neuropathy symptoms on retatrutide.

Neuropathy? — Reddit, r/Retatrutide (source s18)

User neuropathy experience.

Anyone Found Relief from Skin Sensitivity — Reddit, r/RetatrutideTrial (source s19)

Skin sensitivity reports.

Peripheral Neuropathy — Reddit, r/Retatrutide (source s20)

Peripheral neuropathy discussion.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Explore this article's relationships

Neuropathy (general) · condition map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
Evidence · 12 sources · swipe →chain c96055b30d90 · verify chain · provenance
1 / 12
Evidence ledger 6 · tier-ranked · API
human
No human trials test retatrutide for neuropathy treatment.
sources: s9, s11
human
Phase 2/3 trials report dysesthesia in 2-20.9% at higher doses.
sources: s2, s4, s5, s17
human
Weight loss in trials reached 16.9-28%.
sources: s9, s11, s23
mechanistic
Dysesthesia linked possibly to glucagon receptor or metabolic shifts.
sources: s2, s4, s8
anecdotal
X posts describe transient nerve-like sensations during use.
sources: s2
1 more ranked claim
anecdotal0.22low confidence
Reddit users report new tingling or hypersensitivity on retatrutide.
grok/grok-4.3
sources: s0, s18, s19, s20
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-30 00:56
Retatrutide for Neuropathy: Evidence Review · 6 claims · 12 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: Retatrutide for Neuropathy
Slug: retatrutide-neuropathy
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_focus","condition":null,"condition_key":null,"primary_peptide":null,"peptides_in_scope":[{"id":"retatrutide","name":"Retatrutide"}],"drugs_in_scope":[],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaking down","degenerative_w
it output
{"slug":"retatrutide-neuropathy","title":"Retatrutide for Neuropathy: Evidence Review","body":"## What's breaking down\n\nNeuropathy involves degeneration of peripheral nerves. Layers include metabolic stress from high blood sugar or excess weight, chronic low-grade inflammation, and impaired nerve repair signals. In diabetic cases, prolonged hyperglycemia damages small blood vessels that supply nerves, leading to sensory loss, pain, or tingling. Excess body weight adds indirect pressure through poorer circulation and higher systemic load on tissues. Repair pathways lag behind breakdown when metabolic control stays poor. Retatrutide is studied mainly for weight and glucose effects, not as a direct nerve regenerator.\n\n## Why Retatrutide might help you\n\n1. **What keeps failing:** Excess body weight multiplies compressive load on spine, hips, knees, and plantar fascia. This mechanical burden can worsen nerve compression or circulation issues in neuropathy.\n2. **What Retatrutide is studied to do:** Studied for GLP-1/GIP/glucagon-driven weight loss — less mechanical load, not direct disc regeneration.\n3. **Therefore for you:** If that layer is part of your problem, Retatrutide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\n\nIf metabolic load contributes to your nerve symptoms through added tissue stress, reduced body weight
164f593625d52851
Machine verification: /api/articles/retatrutide-neuropathy/contributions
Ask this article · 8 suggested prompts

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "No human trials test retatrutide for neuropathy treatment."?
ask retatrutide-neuropathy claim c1 · paste includes §SELF
What does the ledger say about this (human tier): "Phase 2/3 trials report dysesthesia in 2-20.9% at higher doses."?
ask retatrutide-neuropathy claim c2 · paste includes §SELF
What does the ledger say about this (human tier): "Weight loss in trials reached 16.9-28%."?
ask retatrutide-neuropathy claim c3 · paste includes §SELF
What does the ledger say about this (mechanistic tier): "Dysesthesia linked possibly to glucagon receptor or metabolic shifts."?
ask retatrutide-neuropathy claim c4 · paste includes §SELF
What does the ledger say about this (anecdotal tier): "X posts describe transient nerve-like sensations during use."?
ask retatrutide-neuropathy claim c6 · paste includes §SELF
What does the ledger say about this (anecdotal tier): "Reddit users report new tingling or hypersensitivity on retatrutide."?
ask retatrutide-neuropathy claim c5 · paste includes §SELF
Summarize this reddit report and how it should weigh: "User report of neuropathy symptoms on retatrutide."
ask retatrutide-neuropathy source s0 · paste includes §SELF
Summarize this reddit report and how it should weigh: "User neuropathy experience."
ask retatrutide-neuropathy source s18 · paste includes §SELF
retatrutide-neuropathy · posted 2026-06-29 · updated 2026-07-17 · 1 prior revision · grok/grok-4.3
Ledger API & provenance
Provenance · 2 model passes · 18893 tokens · $0 · 2 models
chain head 679fb555d1846bca
write grok/grok-4.3 · 2026-06-30 00:56 · 18893 tok · 7dc327c29408
voxel_divide owner · 2026-07-17 02:41 · 0 tok · 679fb555d184
verify chain →
Live ledger · 4 payloads · 1 turn
recent activity · inspect
JCI_TRAFFIC jci · HTTP 200 · 2026-07-19 06:56
JCI_CLASSIFY jci · HTTP 200 · 2026-07-19 06:56
PROTOCOL_RUN dispatch · 2026-06-30 00:56 · t_jph79ko8
PROTOCOL_RUN dispatch · 2026-06-30 00:56 · t_jph79ko8
view full ledger & cards →
REST + ledger
read GET /api/articles/retatrutide-neuropathy · GET /api/articles/retatrutide-neuropathy?format=post (the editable body)
create/replace POST /api/articles/retatrutide-neuropathy · PUT /api/articles/retatrutide-neuropathy (replace, keeps revision) · PATCH /api/articles/retatrutide-neuropathy (merge)
delete DELETE /api/articles/retatrutide-neuropathy
writes need header x-terminal-key
LLM bundle GET /api/articles/retatrutide-neuropathy/bundle?format=markdown — body + claims + sources + provenance + manifest
post claim POST /api/protocol/claim · iMessage claim retatrutide-neuropathy|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →
Loading more articles…